
GM1 gangliosidosis: A <a href="https://www.medicinenet.com/script/main/art.asp?articlekey=3573">genetic</a> <a href="https://www.medicinenet.com/script/main/art.asp?articlekey=4168">lipid</a> storage disorder that is similar in certain respects to <a href="https://www.medicinenet.com/script/main/art.asp?articlekey=3821">Hurler syndrome</a> and <a href="https://www.medicinenet.com/script/main/art.asp?articlekey=6308">Tay-Sachs disease</a> but which affects both the brain and the <a href="https://www.medicinenet.com/script/main/art.asp?articlekey=18276">viscera</a> (the internal organs). GM1 gangliosidosis causes <a href="https://www.medicinenet.com/script/main/art.asp?articlekey=16376">skeletal</a> deformities and exerts severe effects on the brain and internal organs. Death usually occurs by the age of 2. 

GM1 gangliosidosis is one of the classic lipid 
storage diseases. The gene responsible for it maps to <a href="https://www.medicinenet.com/script/main/art.asp?articlekey=14018">chromosome</a> 3. There is no treatment for the disease. It is also known as familial neurovisceral lipidosis and Landing disease (after the pioneering pediatric pathologist Ben Landing).

See also <a href="https://www.medicinenet.com/script/main/art.asp?articlekey=3821">Hurler syndrome</a> and <a href="https://www.medicinenet.com/script/main/art.asp?articlekey=6308">Tay-Sachs disease</a>.